TY - JOUR
T1 - Varicella zoster-associated acute retinal necrosis and central nervous system complications in natalizumab treated MS patients
AU - van Kempen, Zoé L. E.
AU - van Rossum, Johannis A.
AU - Hoogervorst, Erwin
AU - Strijbis, Eva
AU - Toorop, Alyssa
AU - Bosscha, Machteld I.
AU - Frequin, Stephan
AU - Dam-van Loon, Ninette ten
AU - Wattjes, Mike P.
AU - Murk, Jean-Luc
AU - Killestein, Joep
AU - Uitdehaag, Bernard M. J.
N1 - Publisher Copyright: © 2021
PY - 2021/5/1
Y1 - 2021/5/1
N2 - There is not much awareness of varicella zoster virus (VZV) associated central nervous system (CNS) infections under treatment with natalizumab. Here we describe two natalizumab treated MS patients who developed acute retinal necrosis combined with CNS vasculitis caused by VZV. In natalizumab treated patients, visual symptoms atypical of optic neuritis should be promptly evaluated by an ophthalmologist. Currently, a total of 12 cases of natalizumab-associated VZV CNS or retinal infections are reported in literature. Our two cases and overview of currently available data provide information on prognosis and treatment decisions of this rare but devastating complication.
AB - There is not much awareness of varicella zoster virus (VZV) associated central nervous system (CNS) infections under treatment with natalizumab. Here we describe two natalizumab treated MS patients who developed acute retinal necrosis combined with CNS vasculitis caused by VZV. In natalizumab treated patients, visual symptoms atypical of optic neuritis should be promptly evaluated by an ophthalmologist. Currently, a total of 12 cases of natalizumab-associated VZV CNS or retinal infections are reported in literature. Our two cases and overview of currently available data provide information on prognosis and treatment decisions of this rare but devastating complication.
KW - Multiple sclerosis
KW - Natalizumab
KW - Retinal necrosis
KW - Varicella zoster
KW - Vasculitis
UR - http://www.scopus.com/inward/record.url?scp=85101394314&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.msard.2021.102838
DO - https://doi.org/10.1016/j.msard.2021.102838
M3 - Comment/Letter to the editor
C2 - 33609925
SN - 2211-0348
VL - 50
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
M1 - 102838
ER -